Bank Of America Corp Vertex Pharmaceuticals Inc Put Options Transaction History

Bank Of America Corp

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $1.93 Million - $2.12 Million	-4,200 Reduced 17.14%	20,300 $9.44 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $5.85 Million - $7.23 Million	-14,900 Reduced 37.82%	24,500 $11.5 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $27.5 Million - $30.1 Million	-67,500 Reduced 63.14%	39,400 $16.5 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $11.9 Million - $14.2 Million	34,600 Added 47.86%	106,900 $43.5 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $7.51 Million - $8.41 Million	23,900 Added 49.38%	72,300 $25.4 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $1.42 Million - $1.62 Million	5,000 Added 11.52%	48,400 $15.2 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $2.8 Million - $3.15 Million	9,800 Added 29.17%	43,400 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $5.04 Million - $5.62 Million	18,400 Added 121.05%	33,600 $9.73 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $3.29 Million - $4.1 Million	-14,000 Reduced 47.95%	15,200 $4.28 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $6.16 Million - $7.25 Million	27,800 Added 1985.71%	29,200 $7.62 Million
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $4.21 Million - $5.32 Million	-23,800 Reduced 94.44%	1,400 $307,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $30.3 Million - $33.9 Million	-166,800 Reduced 86.88%	25,200 $4.57 Million
Q2 2021 Sep 13, 2021	BUY	$187.49 - $221.1 $36 Million - $42.5 Million	192,000 New	192,000 $38.7 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.